DK3140265T3 - Fremgangsmåde til at opnå optisk aktive pirlindolenantiomerer og salte deraf - Google Patents

Fremgangsmåde til at opnå optisk aktive pirlindolenantiomerer og salte deraf Download PDF

Info

Publication number
DK3140265T3
DK3140265T3 DK14726442T DK14726442T DK3140265T3 DK 3140265 T3 DK3140265 T3 DK 3140265T3 DK 14726442 T DK14726442 T DK 14726442T DK 14726442 T DK14726442 T DK 14726442T DK 3140265 T3 DK3140265 T3 DK 3140265T3
Authority
DK
Denmark
Prior art keywords
indolenients
pirl
getting
salts
procedure
Prior art date
Application number
DK14726442T
Other languages
English (en)
Inventor
Oliveira Santos Pedro Paulo De Lacerda E
Filipe Augusto Eugénio Pardal
Pedroso Pedro Filipe EufrãSio
Pecorelli Susana Marques Almeida
Caixado Carlos Alberto Eufrásio Casimiro
João Carlos Ramos Damil
Ana Sofia Da Conceição Lopes
Original Assignee
Tecnimede Sociedade Tecnico Medicinal S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tecnimede Sociedade Tecnico Medicinal S filed Critical Tecnimede Sociedade Tecnico Medicinal S
Application granted granted Critical
Publication of DK3140265T3 publication Critical patent/DK3140265T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B57/00—Separation of optically-active compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
DK14726442T 2014-05-09 2014-05-09 Fremgangsmåde til at opnå optisk aktive pirlindolenantiomerer og salte deraf DK3140265T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/PT2014/000027 WO2015171003A1 (en) 2014-05-09 2014-05-09 Process for obtaining optically active pirlindole enantiomers and salts thereof

Publications (1)

Publication Number Publication Date
DK3140265T3 true DK3140265T3 (da) 2019-11-18

Family

ID=50819929

Family Applications (1)

Application Number Title Priority Date Filing Date
DK14726442T DK3140265T3 (da) 2014-05-09 2014-05-09 Fremgangsmåde til at opnå optisk aktive pirlindolenantiomerer og salte deraf

Country Status (30)

Country Link
US (1) US9682986B2 (da)
EP (1) EP3140265B1 (da)
JP (1) JP6516769B2 (da)
KR (1) KR102258709B1 (da)
CN (1) CN106414376B (da)
AU (1) AU2014393488C1 (da)
BR (1) BR112016025918B1 (da)
CA (1) CA2948604C (da)
CY (1) CY1122367T1 (da)
DK (1) DK3140265T3 (da)
EC (1) ECSP16086217A (da)
ES (1) ES2753403T3 (da)
HR (1) HRP20192029T1 (da)
HU (1) HUE046437T2 (da)
IL (1) IL248853B (da)
LT (1) LT3140265T (da)
MA (1) MA39449A1 (da)
MX (1) MX357918B (da)
NZ (1) NZ726129A (da)
PH (1) PH12016502234A1 (da)
PL (1) PL3140265T3 (da)
PT (1) PT3140265T (da)
RS (1) RS59499B1 (da)
RU (1) RU2666731C2 (da)
SA (1) SA516380265B1 (da)
SI (1) SI3140265T1 (da)
TN (1) TN2016000496A1 (da)
UA (1) UA118696C2 (da)
WO (1) WO2015171003A1 (da)
ZA (1) ZA201607722B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2988983T3 (es) * 2014-05-09 2024-11-22 Tecnimede Sociedade Tecnico Medicinal S Sales de mandelato de enantiómeros de pirlindol para uso en medicina
RU2666731C2 (ru) 2014-05-09 2018-09-12 Текнимеди Сосьедади Текнику-Медисинал С.А. Способ получения оптически активных энантиомеров пирлиндола и его солей
EP3392250A1 (en) 2017-04-21 2018-10-24 Tecnimede-Sociedade Tecnico-Medicinal, S.A. Process for the preparation of piperazine ring for the synthesis of pyrazinocarbazole derivatives
EP3392251A1 (en) 2017-04-21 2018-10-24 Tecnimede-Sociedade Tecnico-Medicinal, S.A. Process for the preparation of pirlindole enantiomers and its salts
US12667555B2 (en) 2022-05-20 2026-06-30 Springworks Therapeutics, Inc. Treatment of ovarian cancer with nirogacestat

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2281085C2 (ru) * 2004-05-25 2006-08-10 Закрытое акционерное общество "Мастерлек" Антидепрессивные лекарственные средства для парентерального применения на основе сульфонатных солей пирлиндола
RU2666731C2 (ru) 2014-05-09 2018-09-12 Текнимеди Сосьедади Текнику-Медисинал С.А. Способ получения оптически активных энантиомеров пирлиндола и его солей

Also Published As

Publication number Publication date
UA118696C2 (uk) 2019-02-25
EP3140265B1 (en) 2019-08-28
NZ726129A (en) 2019-03-29
EP3140265A1 (en) 2017-03-15
RU2666731C2 (ru) 2018-09-12
MA39449A1 (fr) 2017-11-30
RS59499B1 (sr) 2019-12-31
SA516380265B1 (ar) 2019-11-04
AU2014393488C1 (en) 2020-07-16
CA2948604C (en) 2021-06-15
MX357918B (es) 2018-07-30
AU2014393488B2 (en) 2018-11-08
PH12016502234B1 (en) 2017-01-09
PL3140265T3 (pl) 2020-02-28
RU2016148181A (ru) 2018-06-13
HUE046437T2 (hu) 2020-03-30
SI3140265T1 (sl) 2019-12-31
MX2016014703A (es) 2017-05-23
ZA201607722B (en) 2022-05-25
US20170145024A1 (en) 2017-05-25
BR112016025918A2 (da) 2017-08-15
TN2016000496A1 (en) 2018-04-04
HRP20192029T1 (hr) 2020-02-07
AU2014393488A1 (en) 2016-11-24
WO2015171003A1 (en) 2015-11-12
RU2016148181A3 (da) 2018-06-13
KR20170004995A (ko) 2017-01-11
KR102258709B1 (ko) 2021-06-01
CY1122367T1 (el) 2021-01-27
JP6516769B2 (ja) 2019-05-22
IL248853A0 (en) 2017-01-31
CA2948604A1 (en) 2015-11-12
LT3140265T (lt) 2019-12-10
IL248853B (en) 2020-01-30
CN106414376B (zh) 2019-06-07
US9682986B2 (en) 2017-06-20
ES2753403T3 (es) 2020-04-08
PH12016502234A1 (en) 2017-01-09
CN106414376A (zh) 2017-02-15
PT3140265T (pt) 2019-12-02
ECSP16086217A (es) 2017-02-24
BR112016025918B1 (pt) 2023-05-16
JP2017514883A (ja) 2017-06-08

Similar Documents

Publication Publication Date Title
DK3389778T3 (da) Indretning til fotodynamisk behandling
DK3984996T3 (da) Aminopyridin-SSAO-inhibitorer
PL3970906T3 (pl) Sposoby i układy do laserowej ablacji i obróbki
DK3092017T3 (da) Konnektor på engangsindretning til enkeltbrug
DK3090416T3 (da) Fremgangsmåde og system til overvågning
DK3116911T3 (da) Anti-mcam-antistoffer og tilhørende fremgangsmåder til anvendelse
DK3256076T3 (da) Hjerteklapdockingindretning
DK3227262T3 (da) Sulfidalkyl og pyridyl-revers-sulfonamidforbindelser til hbv-behandling
DK3227336T3 (da) Anti-CD79b-antistoffer og fremgangsmåder til anvendelse
DK3202305T3 (da) Engangsendoskop og system
DK3102123T3 (da) Tourniquet til ekstremiteter
IL239642B (en) Wavefront analysis based on ablation parameters
HRP20181941T1 (hr) Alat za njegu i postupak
IL251097B (en) Neural microphysiological systems and methods of using the same
DK3197354T3 (da) Medicinsk anordning
DK3139903T3 (da) Vandig oftalmisk opløsning og fremgangsmåde til behandling af tørre øjne-syndrom
FI20145671A7 (fi) Kannettava laite aktiviteetin seuraamiseksi ja siihen liittyvä menetelmä
DK3103715T3 (da) Styreindretning og styringsfremgangsmåde dertil
EP3135426C0 (en) LASER MACHINING DEVICE
DK3101760T3 (da) Opladningsfremgangsmåde og system
BR112017000042A2 (pt) inibidores de desmetilase-1 lisina-específica
IL252224A0 (en) Systems and methods for performing electrocardiograms
EP3215219C0 (en) SKIN TREATMENT SYSTEM
EP3120189C0 (en) LASER PROJECTION SYSTEM
IL246658B (en) Systems and methods for diagnosing sleep